CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $993,000 | -17.8% | 66,353 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $1,208,000 | -25.2% | 66,353 | -6.2% | 0.01% | -22.2% |
| Q2 2018 | $1,616,000 | -13.6% | 70,709 | +6.1% | 0.01% | -18.2% |
| Q1 2018 | $1,871,000 | +33.1% | 66,621 | 0.0% | 0.01% | +37.5% |
| Q4 2017 | $1,406,000 | +91.3% | 66,621 | +64.7% | 0.01% | +100.0% |
| Q3 2017 | $735,000 | – | 40,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
| Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
| Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
| RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
| Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
| Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
| WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |